These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 15946654

  • 1. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes.
    Ho LJ, Lin LC, Hung LF, Wang SJ, Lee CH, Chang DM, Lai JH, Tai TY.
    Biochem Pharmacol; 2005 Jul 15; 70(2):200-8. PubMed ID: 15946654
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.
    Arthritis Res Ther; 2007 Jul 15; 9(2):R31. PubMed ID: 17386086
    [Abstract] [Full Text] [Related]

  • 3. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
    Ahmed S, Rahman A, Hasnain A, Goldberg VM, Haqqi TM.
    J Pharmacol Exp Ther; 2003 Jun 15; 305(3):981-8. PubMed ID: 12626640
    [Abstract] [Full Text] [Related]

  • 4. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
    Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A.
    Biochem Pharmacol; 2007 May 01; 73(9):1434-45. PubMed ID: 17291458
    [Abstract] [Full Text] [Related]

  • 5. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R, Ahmed S, Malemud CJ, Goldberg VM, Haqqi TM.
    J Orthop Res; 2003 Jan 01; 21(1):102-9. PubMed ID: 12507586
    [Abstract] [Full Text] [Related]

  • 6. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes.
    Kim HA, Yeo Y, Kim WU, Kim S.
    Rheumatology (Oxford); 2009 Aug 01; 48(8):932-8. PubMed ID: 19491303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.
    Pufe T, Harde V, Petersen W, Goldring MB, Tillmann B, Mentlein R.
    J Pathol; 2004 Mar 01; 202(3):367-74. PubMed ID: 14991903
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes.
    Forsyth CB, Pulai J, Loeser RF.
    Arthritis Rheum; 2002 Sep 01; 46(9):2368-76. PubMed ID: 12355484
    [Abstract] [Full Text] [Related]

  • 12. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC, Martel-Pelletier J, Pelletier JP.
    Biorheology; 2002 Sep 01; 39(1-2):237-46. PubMed ID: 12082286
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
    Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, Kim HY.
    Arthritis Rheum; 2006 Jul 01; 54(7):2152-63. PubMed ID: 16802353
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
    Wen D, Nong Y, Morgan JG, Gangurde P, Bielecki A, Dasilva J, Keaveney M, Cheng H, Fraser C, Schopf L, Hepperle M, Harriman G, Jaffee BD, Ocain TD, Xu Y.
    J Pharmacol Exp Ther; 2006 Jun 01; 317(3):989-1001. PubMed ID: 16525037
    [Abstract] [Full Text] [Related]

  • 17. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
    Oyama T, Matsushita K, Sakuta T, Tokuda M, Tatsuyama S, Nagaoka S, Torii M.
    J Periodontal Res; 2007 Feb 01; 42(1):53-61. PubMed ID: 17214640
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways.
    Cho ML, Jung YO, Moon YM, Min SY, Yoon CH, Lee SH, Park SH, Cho CS, Jue DM, Kim HY.
    Immunol Lett; 2006 Mar 15; 103(2):159-66. PubMed ID: 16368150
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.